Table 3.
IFG | ||
---|---|---|
Characteristic | Unadjusted Odds Ratio (95% CI) | *Adjusted Odds Ratio (95% CI) |
Non-Caucasian Race** (vs. Caucasians) | 23.1 (2.8–187.0) | 24.7 (3.0–206.3) |
Inflammation on Liver Biopsy (Grade ≥ 2 vs. < 2) | 7.9 (1.2–53.4) | 11.0 (1.4–87.0) |
BMI (per 5 units), kg/m2 | 3.4 (1.2–9.8) | 3.1 (1.07–8.9) |
IGT (Isolated IGT or IFG/IGT) | ||
Characteristic | Unadjusted Odds Ratio (95% CI) | †Adjusted Odds Ratio (95% CI) |
SSPG (per 10 units), mg/dL | 1.1 (1.02–1.2) | 1.1 (1.01–1.2) |
Non-Caucasian Race** (vs. Caucasians) | 14.8 (1.7–127.3) | 19.7 (1.7–224.3) |
Adjusted for age, sex, and HCV genotype.
Adjusted for age, sex, BMI, and HCV genotype.
Each of the non-Caucasian racial categories had a positive association with pre-diabetes and these races were combined due to small sample size to improve the precision of the point estimates.
BMI, body mass index; HCV, hepatitis C virus; SSPG, steady-state plasma glucose.